SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-004572
Filing Date
2018-01-05
Accepted
2018-01-05 16:53:03
Documents
6
Period of Report
2018-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d518825d8k.htm 8-K 20638
2 EX-1.1 d518825dex11.htm EX-1.1 212673
3 EX-5.1 d518825dex51.htm EX-5.1 16814
4 EX-99.1 d518825dex991.htm EX-99.1 8780
5 EX-99.2 d518825dex992.htm EX-99.2 8946
6 GRAPHIC g518825g0105105127407.jpg GRAPHIC 2222
  Complete submission text file 0001193125-18-004572.txt   272197
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 18513988
SIC: 2836 Biological Products, (No Diagnostic Substances)